Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Positive phase III results for Lidakol in oral herpes

Aug. 19, 1997

U.S. patent issued for Candida albicans treatment method

Aug. 18, 1997

Teva's problems with clindamycin

Aug. 13, 1997

AmBisome cleared by FDA

Aug. 13, 1997

Settlement reached in NeXstar and The Liposome Company patent litigation

Aug. 12, 1997

Oral carbapenem antibacterial agents from Lederle (Japan)

Aug. 11, 1997

AmBisome approved in Korea

Aug. 8, 1997

Shionogi's beta-lactam antibiotic launched in Japan

Aug. 7, 1997

CytoGam approved for marketing in Canada

Aug. 7, 1997

AmBisome approved in Russia

Aug. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.